Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK‑STAT pathway
Oncology Reports · 14.04.2026 · 55 (6) · 1-12
DOI: 10.3892/or.2026.9119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 14.04.2026. Verfasst von Yongyang Yun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, Beijing 100034, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, STAT3 Transcription Factor, Mucin-3. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Peking University First Hospital, Beijing 100034, P.R. China.
Zitieren
APA
Yun, Y., Ji, X., Hu, S., Wu, T., Liu, Y., Li, Z., Sun, Z., Zhou, P., Yang, L., & Yu, W. (2026). Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK‑STAT pathway. Oncology Reports, 55(6), 1-12. https://doi.org/10.3892/or.2026.9119
Vancouver
Yun Y, Ji X, Hu S, Wu T, Liu Y, Li Z, et al. Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK‑STAT pathway. Oncology Reports. 2026;55(6):1-12. doi:10.3892/or.2026.9119
BibTeX
@article{Yun2026,
author = {Yun, Yongyang and Ji, Xing and Hu, Shuai and Wu, Tianyu and Liu, Yixiao and Li, Zheng and Sun, Zhoujie and Zhou, Peimin and Yang, Lei and Yu, Wei},
title = {Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAK‑STAT pathway},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {6},
pages = {1--12},
doi = {10.3892/or.2026.9119}
}
EUVIMED